CSA Medical has raised approximately $50.3 million in separate equity and debt rounds, according to recently posted SEC filings.
In its equity funding round, the Lexington, Mass.-based company raised approximately $45.2 million from 37 unnamed sources, with the first sale noted on January 25, 2019.
CSA Medical is still looking for $2.5 million in the round, which would bring the equity funding round to a total of $47.7 million, according to the SEC filing.
In its debt financing round, the company raised approximately $5.1 million from 39 unnamed sources, with the first date of sale noted as having occurred on December 21, 2017.
CSA Medical is not looking to raise any more funds in the debt financing round, according to the SEC filing.
The company has not yet stated how it plans to spend funds raised in either rounds.
Last October, CSA Medical said that it put a $23 million debt-and-equity round on ice for the cryospray technology it’s developing.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.